Evaluating the value of continuing docetaxel and prednisone (DP) beyond 10 cycles in men with metastatic castration-resistant prostate cancer (mCRPC).
Journal Article
Full Text
Duke Authors
Cited Authors
- Pond, GR; Armstrong, AJ; Wood, BA; Brookes, M; Leopold, LH; Berry, WR; De Wit, R; Eisenberger, MA; Tannock, I; Sonpavde, G
Published Date
- May 20, 2011
Published In
Volume / Issue
- 29 / 15_suppl
Start / End Page
- 4582 - 4582
Published By
Electronic International Standard Serial Number (EISSN)
- 1527-7755
International Standard Serial Number (ISSN)
- 0732-183X
Digital Object Identifier (DOI)
- 10.1200/jco.2011.29.15_suppl.4582
Language
- en